tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CytoDyn announces data on mechanism of action of leronlimab
PremiumThe FlyCytoDyn announces data on mechanism of action of leronlimab
5M ago
CytoDyn Appoints Robert Hoffman as New CFO
Premium
Company Announcements
CytoDyn Appoints Robert Hoffman as New CFO
6M ago
CytoDyn appoints Robert Hoffman as CFO
Premium
The Fly
CytoDyn appoints Robert Hoffman as CFO
6M ago
CytoDyn CEO believes current strategy will result in ‘significant value return’
PremiumThe FlyCytoDyn CEO believes current strategy will result in ‘significant value return’
10M ago
CytoDyn appoints Richard Pestell as lead consultant in oncology
Premium
The Fly
CytoDyn appoints Richard Pestell as lead consultant in oncology
11M ago
CytoDyn announces FDA clearance of Phase II oncology trial
Premium
The Fly
CytoDyn announces FDA clearance of Phase II oncology trial
12M ago
CytoDyn CEO says leronlimab has ‘potential to be life-changing therapeutic’
PremiumThe FlyCytoDyn CEO says leronlimab has ‘potential to be life-changing therapeutic’
1y ago
CytoDyn engages CRO for Phase II inflammation trial
Premium
The Fly
CytoDyn engages CRO for Phase II inflammation trial
1y ago
CytoDyn completes FDA meeting on Phase II Study of leronlimab
Premium
The Fly
CytoDyn completes FDA meeting on Phase II Study of leronlimab
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100